Patent | Date |
---|
Methods involving long lasting synthetic exendin-4 peptide conjugates Grant 8,093,206 - Bridon , et al. January 10, 2 | 2012-01-10 |
Methods involving long lasting synthetic exendin-4-peptide conjugates Grant 8,084,414 - Bridon , et al. December 27, 2 | 2011-12-27 |
Long lasting synthetic exendin-4 peptide conjugates Grant 8,080,516 - Bridon , et al. December 20, 2 | 2011-12-20 |
Modified therapeutic peptides with extended half-lives in vivo App 20090175821 - Bridon; Dominique P. ;   et al. | 2009-07-09 |
Protection of exendin-4 peptides through conjugation App 20090093408 - Bridon; Dominique P. ;   et al. | 2009-04-09 |
Long lasting synthetic exendin-4 peptide conjugates and methods of use thereof App 20090075890 - Bridon; Dominique P. ;   et al. | 2009-03-19 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components Grant 7,256,253 - Bridon , et al. August 14, 2 | 2007-08-14 |
Affinity markers for human serum albumin Grant 7,166,695 - Krantz , et al. January 23, 2 | 2007-01-23 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060135426 - Bridon; Dominique P. ;   et al. | 2006-06-22 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060058235 - Bridon; Dominique P. ;   et al. | 2006-03-16 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060009377 - Bridon; Dominique P. ;   et al. | 2006-01-12 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components App 20050187159 - Bridon, Dominique P. ;   et al. | 2005-08-25 |
Long lasting synthetic glucagon-like peptide {GLP-1} Grant 6,887,849 - Bridon , et al. May 3, 2 | 2005-05-03 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components Grant 6,887,470 - Bridon , et al. May 3, 2 | 2005-05-03 |
Affinity markers for human serum albumin App 20050037974 - Krantz, Alexander ;   et al. | 2005-02-17 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components Grant 6,849,714 - Bridon , et al. February 1, 2 | 2005-02-01 |
Long lasting synthetic glucagon-like peptide (GLP-1) Grant 6,821,949 - Bridon , et al. November 23, 2 | 2004-11-23 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20040138100 - Bridon, Dominique ;   et al. | 2004-07-15 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20040127398 - Bridon, Dominique P. ;   et al. | 2004-07-01 |
Local delivery of long lasting therapeutic agents App 20030170250 - Ezrin, Alan M. ;   et al. | 2003-09-11 |
Method for alleviating pain or providing an analgesic effect in a patient Grant 6,610,825 - Ezrin , et al. August 26, 2 | 2003-08-26 |
Antinociceptive agent derivative Grant 6,602,981 - Ezrin , et al. August 5, 2 | 2003-08-05 |
Long lasting insulinotropic peptides Grant 6,593,295 - Bridon , et al. July 15, 2 | 2003-07-15 |
Long lasting synthetic glucagon-like peptide {GLP-1} App 20030108567 - Bridon, Dominique P. ;   et al. | 2003-06-12 |
Long lasting synthetic glucagon-like peptide {GLP-1} App 20030108568 - Bridon, Dominique P. ;   et al. | 2003-06-12 |
Long lasting synthetic glucagon like peptide {GLP-!} Grant 6,514,500 - Bridon , et al. February 4, 2 | 2003-02-04 |
Conjugate comprising an antinociceptive agent covalently bonded to a blood component Grant 6,500,918 - Ezrin , et al. December 31, 2 | 2002-12-31 |
Long lasting insulinoptropic peptides App 20020049153 - Bridon, Dominique P. ;   et al. | 2002-04-25 |
Antinociceptive agent derivative App 20020039999 - Ezrin, Alan M. ;   et al. | 2002-04-04 |
Long lasting insulinotropic peptides Grant 6,329,336 - Bridon , et al. December 11, 2 | 2001-12-11 |
Method for alleviating pain or providing an analgesic effect in a patient App 20010018420 - Ezrin, Alan M. ;   et al. | 2001-08-30 |
Conjugate comprising an antinociceptive agent covalently bonded to a blood component App 20010018421 - Ezrin, Alan M. ;   et al. | 2001-08-30 |